类风湿关节炎患者术后深静脉血栓形成危险因素分析

doi:10.3877/cma.j.issn.1674-134X.2021.01.008

目的

分析类风湿关节炎患者行全膝关节置换术后深静脉血栓发生情况及分析危险因素。

方法

回顾性分析2010年3月至2018年12月南京鼓楼医院运动医学与成人重建外科116例接受全膝关节置换术的类风湿关节炎患者血栓发生情况，其中男性12例，女性104例，纳入标准为诊断明确，行标准全膝关节置换术，有完整术前术后血栓筛查，排除诊断不明，行部分关节置换，术前存在血栓，合并其他手术指征及术后不能完成血栓筛查的患者。记录年龄，性别，身体质量指数，是否合并高血压、糖尿病、高血脂，术后卧床时间，疼痛视觉模拟评分，按照深静脉血栓发生情况分为血栓组和无血栓组，比较两组血栓发生率及各项指标的差异，分类变量比较采用卡方检验，计量资料比较采用t检验，并采用logistic回归分析验证各危险因素与血栓形成的相关性。

结果

共17例发生深静脉血栓，发生率14.7%(17/116)，所有病例血栓均稳定，无一例发生肺栓塞。血栓组平均年龄(62.8±8.8)岁，高于非血栓组的(56.4±11.1)岁(t＝2.272，P＝0.025)，且血栓组年龄65岁以上人群比例47.1%，高于非血栓组的21.2%(χ²＝3.88，P＝0.049)，多因素回归分析发现年龄≥65岁是术后发生深静脉血栓的独立危险因素(OR＝1.265，P＝0.032)。

结论

类风湿关节炎患者行全膝关节置换术后深静脉血栓发生率不低，年龄≥65岁是类风湿关节炎患者全关节置换术后发生深静脉血栓的独立危险因素，建议对老年患者进行更为积极的血栓预防。

关键词: 关节炎, 类风湿, 关节成形术, 置换, 膝, 静脉血栓形成, 危险因素

Objective

To analyze the incidence of deep venous thrombosis after total knee arthroplasty in patients with rheumatoid arthritis and to analyze the risk factors.

Methods

One hundred and sixteen cases of rheumatoid arthritis patients undergoing total knee arthroplasty in the Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital from March 2010 to December 2018 were retrospectively analyzed, including 12 males and 104 females. Inclusion criteria were definite diagnosis, standard total knee arthroplasty, and available for preoperative and postoperative examination of thrombosis. Those without definite diagnosis, treated with unicompartmental knee arthroplasty, with preoperative thrombosis or unable to accept relating examinations were excluded. Age, gender, body mass index, hypertension, diabetes, triglycerides, postoperative bed rest time and pain visual analogue scale score were recorded. The patients were divided into thrombosis group and non-thrombosis group according to the incidence of deep vein thrombosis, and the difference of figures were compared. Chi-square test was used to examine categorical variables, and paired t test was adopted for metering data. Logistic regression analysis was used to verify the correlation of various risk factors and thrombosis.

Results

Seventeen cases developed deep vein thrombosis, and the incidence rate was 14.7% (17/116). All the thrombosis was stable and no pulmonary embolism occurred. Thrombosis group had higher average age than the non-thrombosis group[(62.8±8.8) vs (56.4±11.1)years, t =2.272, P=0.025], and the proportion of people over 65 years old in thrombosis group was 47.1%, higher than 21.2% of the non-thrombosis group (χ²=3.88, P=0.049). Multivariate regression analysis revealed that age ≥65 years was an independent risk factor of postoperative deep vein thrombosis (OR=1.265, P =0.032).

Conclusions

The incidence of deep vein thrombosis after total knee arthroplasty in patients with rheumatoid arthritis is not low. Age ≥ 65 years is an independent risk factor for deep vein thrombosis after total joint replacement in patients with rheumatoid arthritis and it is suggested to conduct more aggressive thromboprophylaxis to those patients.

Key words: Arthritis, rheumatoid, Arthroplasty, replacement, knee, Venous thrombosis, Risk factors

表1 类风湿关节炎患者全膝关节置换术后深静脉血栓发生危险因素的单因素分析

	无血栓组	血栓组	统计值	P值
例数	99	17
性别[男，例(%)]	11(11.1)	1(5.9)	χ²＝0.050	>0.05
年龄≥65岁[例(%)]	21(21.2)	8(47.1)	χ²＝3.883	0.049
合并高血压[例(%)]	30(30.3)	4(23.5)	χ²＝0.078	>0.05
合并糖尿病[例(%)]	11(11.1)	4(23.5)	χ²＝1.037	>0.05
年龄[岁，(±s)]	56.4±11.1	62.8±8.8	t ＝2.272	0.025
卧床时间[d，(±s)]	3.1±1.1	3.0±1.2	t＝0.203	>0.05
甘油三酯[mmol/L，(±s)]	1.2±0.6	1.3±0.6	t＝2.063	>0.05
VAS评分(±s)	2.9±1.5	2.2±1.6	t＝1.553	>0.05
BMI[kg/m²，(±s)]	23.1±4.7	23.8±3.4	t＝0.594	>0.05

表1 类风湿关节炎患者全膝关节置换术后深静脉血栓发生危险因素的单因素分析

	无血栓组	血栓组	统计值	P值
例数	99	17
性别[男，例(%)]	11(11.1)	1(5.9)	χ²＝0.050	>0.05
年龄≥65岁[例(%)]	21(21.2)	8(47.1)	χ²＝3.883	0.049
合并高血压[例(%)]	30(30.3)	4(23.5)	χ²＝0.078	>0.05
合并糖尿病[例(%)]	11(11.1)	4(23.5)	χ²＝1.037	>0.05
年龄[岁，(±s)]	56.4±11.1	62.8±8.8	t ＝2.272	0.025
卧床时间[d，(±s)]	3.1±1.1	3.0±1.2	t＝0.203	>0.05
甘油三酯[mmol/L，(±s)]	1.2±0.6	1.3±0.6	t＝2.063	>0.05
VAS评分(±s)	2.9±1.5	2.2±1.6	t＝1.553	>0.05
BMI[kg/m²，(±s)]	23.1±4.7	23.8±3.4	t＝0.594	>0.05

表2 类风湿关节炎患者全膝关节置换术后深静脉血栓发生危险因素的logistic回归分析

项目	OR值	95%置信区间	P值
性别	2.608	(0.248，27.368)	0.424
老年	1.265	(1.079，1.890)	0.032
高血压	2.949	(0.663，13.116)	0.156
糖尿病	0.364	(0.079，0.890)	0.194
卧床时间	1.352	(0.463，3.953)	0.156
VAS	0.716	(0.475，1.081)	0.828
甘油三酯	1.352	(0.463，3.953)	0.581
BMI	1.052	(0.926，1.194)	0.437

表2 类风湿关节炎患者全膝关节置换术后深静脉血栓发生危险因素的logistic回归分析

项目	OR值	95%置信区间	P值
性别	2.608	(0.248，27.368)	0.424
老年	1.265	(1.079，1.890)	0.032
高血压	2.949	(0.663，13.116)	0.156
糖尿病	0.364	(0.079，0.890)	0.194
卧床时间	1.352	(0.463，3.953)	0.156
VAS	0.716	(0.475，1.081)	0.828
甘油三酯	1.352	(0.463，3.953)	0.581
BMI	1.052	(0.926，1.194)	0.437

[1]	Chung WS, Peng CL, Lin CL, et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study[J]. Ann Rheum Dis, 2014, 73(10): 1774-1780.
[2]	Wang CJ, Wang JW, Weng LH, et al. Outcome of calf deep-vein thrombosis after total knee arthroplasty[J]. J Bone Joint Surg Br, 2003, 85(6): 841-844.
[3]	Leutz DW, Stauffer ES. Color duplex Doppler ultrasound scanning for detection of deep venous thrombosis in total knee and hip arthroplasty patients. Incidence, location, and diagnostic accuracy compared with ascending venography[J]. J Arthroplasty, 1994, 9(5): 543-548.
[4]	Gromadziński L, Targoński R, Januszko-Giergielewicz B, et al. The influence of acute pulmonary embolism on early and delayed prognosis for patients with chronic heart failure[J]. Cardiol J, 2012, 19(6): 625-631.
[5]	Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study [J/OL]. BMC Med, 2011, 9: 1. doi: 10.1186/1741-7015-9-1.
[6]	Yoshitaka T, Abe N, Minagawa H, et al. Disease-specific screening for deep venous thrombosis and pulmonary thromboembolism using plasma D-dimer values after total knee arthroplasty[J]. Mod Rheumatol, 2008, 18(4): 359-365.
[7]	Chotanaphuti T, Ongnamthip P, Songpatanasil T, et al. Risk factors of deep vein thrombosis (DVT) after total knee arthroplasty (TKA) at Phramongkutklao Hospital[J]. J Med Assoc Thai, 2007, 90(3): 485-491.
[8]	Levy YD, Hardwick ME, Copp SN, et al. Thrombosis incidence in unilateral vs. simultaneous bilateral total knee arthroplasty with compression device prophylaxis[J]. J Arthroplasty, 2013, 28(3): 474-478.
[9]	Ogdie A, Kay MN, Shin DB, et al. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study[J]. Eur Heart J, 2018, 39(39): 3608-3614.
[10]	Burn E, Edwards CJ, Murray DW, et al. The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study[J]. Clin Epidemiol, 2018, 10(1): 697-704.
[11]	Niki Y, Matsumoto H, Hakozaki A, et al. Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis[J]. J Orthop Sci, 2010, 15(1): 57-63.
[12]	Lee DK, Kim HJ, Lee DH. Incidence of deep vein thrombosis and venous thromboembolism following TKA in rheumatoid arthritis versus osteoarthritis: a meta-analysis[J/OL]. PLoS One, 2016, 11(12): e0166844-0166854. doi: 10.1371/journal.pone.0166844.
[13]	Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988, 31(3): 315-324.
[14]	Izumi M, Migita K, Nakamura M, et al. Risk of venous thromboembolism after total knee arthroplasty in patients with rheumatoid arthritis[J]. J Rheumatol, 2015, 42(6): 928-934.
[15]	Balk EM, Ellis AG, Di M, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry[J]. J Bone Joint Surg Br, 2007, 89(6): 799-807.
[16]	Cho SE, Delate T, Witt DM, et al. Thromboembolic and bleeding outcomes of extended duration low-intensity warfarin following elective total knee arthroplasty[J]. Thromb Res, 2015, 135(2): 267-271.
[17]	庞勇，徐志宏，史冬泉，等．类风湿关节炎膝关节置换后深静脉血栓发生情况及溶栓效果研究[J]．中国矫形外科杂志，2012，20(13)：1165-1167.
[18]	Fu D, Zhao Y, Shen J, et al. Comparison of venous thromboembolism after total artificial joint replacement between musculoskeletal tumors and osteoarthritis of the knee by a single surgeon[J/OL]. PLoS One, 2016, 11(6): e0158215-0158224. doi: 10.1371/journal.pone.0158215.
[19]	Zeng Y, Si H, Wu Y, et al. The incidence of symptomatic in-hospital VTEs in Asian patients undergoing joint arthroplasty was low: a prospective, multicenter, 17, 660-patient-enrolled cohort study[J]. Knee Surg Sports Traumatol Arthrosc, 2019, 27(4): 1075-1082.
[20]	Courtney PM, Boniello AJ, Levine BR, et al. Are revision hip arthroplasty patients at higher risk for venous thromboembolic events than primary hip arthroplasty patients？[J]. J Arthroplasty, 2017, 32(12): 3752-3756.
[21]	Cho SK, Kim D, Won S, et al. Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis[J]. Korean J Intern Med, 2019, 34(4): 910-916.
[22]	Smith AM, Lingard L, Heslop P, et al. Vascular disease as a cause of death in patients with severe disability due to osteoarthritis and rheumatoid arthritis[J]. Springerplus, 2015, 4(1): 328-332.
[23]	Longo MG, Greco A, Pacilli M, et al. Deep venous thrombosis in elderly hospitalized patients: prevalence and clinical features[J]. Aging Clin Exp Res, 2005, 17(1): 42-45.
[24]	Kim KI, Cho KY, Jin W, et al. Recent korean perspective of deep vein thrombosis after total knee arthroplasty[J]. JArthroplasty, 2011, 26(7): 1112-1116.
[25]	Zhao Z, Wang S, Ma W, et al. Diabetes mellitus increases the incidence of deep vein thrombosis after total knee arthroplasty[J]. Arch Orthop Trauma Surg, 2014, 134(1): 79-83.
[26]	Nakao S, Takata S, Uemura H, et al. Early ambulation after total knee arthroplasty prevents patients with osteoarthritis and rheumatoid arthritis from developing postoperative higher levels of D-dimer[J]. J Med Invest, 2010, 57(1/2): 146-151.
[27]	Mi Y, Yan S, Lu Y, et al. Venous thromboembolism has the same risk factors as atherosclerosis: a PRISMA-compliant systemic review and meta-analysis[J/OL]. Medicine (Baltimore), 2016, 95(32): e4495. doi: 10.1097/MD.0000000000004495.
[28]	Line BR. Pathophysiology and diagnosis of deep venous thrombosis[J]. Semin Nucl Med, 2001, 31(2): 90-101.

[1]	王博冉, 乔春梅, 李春歌, 王欣, 王晓磊. 超声造影评估类风湿关节炎亚临床滑膜炎疾病进展的价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(08): 802-808.
[2]	王振宇, 张洪美, 荆琳, 何名江, 闫奇. 膝骨关节炎相关炎症因子与血浆代谢物间的因果关系及中介效应[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 467-473.
[3]	罗文斌, 韩玮. 胰腺癌患者首次化疗后中重度骨髓抑制的相关危险因素分析及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 357-362.
[4]	贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[5]	林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[6]	杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[7]	宋庆成, 郑占乐, 王天瑞, 王宇钏, 张凯旋, 纳静, 蔚佳昊, 杨思繁, 宋九宏, 张英泽. “人老膝不老”：膝关节健康管理的全方位探索与实践[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 321-324.
[8]	郑占乐, 王宇钏, 蔚佳昊, 宋庆成, 张凯旋, 纳静, 王天瑞, 宋九宏, 张英泽, 王娟. 保膝须“开膝”——“开膝”在膝骨关节炎中的临床应用价值[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 325-330.
[9]	茹江英, 廖启宇, 温国洪, 潘思华, 刘栋, 张皓琛, 牛云飞. 直接前方入路和后外侧入路半髋关节置换治疗老年痴呆股骨颈骨折的疗效比较[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 287-293.
[10]	高广涵, 张耀南, 石磊, 王林, 王飞, 郑子天, 王鸿禹, 郭民政, 薛庆云. 膝骨关节炎患者前交叉韧带功能影像学影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 301-307.
[11]	王松雷, 张贻良, 孟浩, 宋威, 白林晨, 袁心, 张辉. 股骨前髁预截骨髓外定位技术在全膝关节置换术中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 811-819.
[12]	马豆豆, 丁艳, 古今, 王丽芳, 石连杰. 以发热为首发表现的强直性脊柱炎合并潜伏性结核感染一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 791-794.
[13]	颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[14]	刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[15]	曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Risk factors for deep vein thrombosis after arthroplasty in patients with rheumatoid arthritis

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Risk factors for deep vein thrombosis after arthroplasty in patients with rheumatoid arthritis